SCHEMBL4186527

SCHEMBL4186527

O=C(O)c1ccc(-c2ncc(Cl)cc2Cl)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH5 P11766 1/20 0.58
MAP2K4 P45985 1/20 0.52
RXRA P19793 1/20 0.51
RXRB P28702 1/20 0.51
SRD5A2 P31213 2/20 0.50
CDH1 P12830 1/20 0.49
APC P25054 1/20 0.49
CTNNB1 P35222 1/20 0.49
TCF7L2 Q9NQB0 1/20 0.49
MAP4K4 O95819 3/20 0.48
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
HCAR2 Q8TDS4 1/20 0.44
NAPRT Q6XQN6 1/20 0.44
CNR2 P34972 1/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
PLAU P00749 1/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
CRHBP P24387 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3340692 0.81 TSHR (0.49) ADH5SRD5A2CDH1APCCTNNB1
SCHEMBL4184573 0.81 TSHR (0.56) ADH5SRD5A2TSHRCNR2SMN1; SMN2
SCHEMBL4179640 0.81 TSHR (0.49) ADH5SRD5A2CDH1APCCTNNB1
SCHEMBL4182244 0.80 NPC1 (0.56) ADH5MAP2K4RXRARXRBMAP4K4
SCHEMBL18356746 0.79 MAPK1 (0.53) TSHRCNR2PLAUNPC1RAB9A
SCHEMBL4191067 0.77 DHODH (0.47) TSHRCNR2SMN1; SMN2MRGPRX4
SCHEMBL14156968 0.77 TSHR (0.56) RXRARXRBSRD5A2MAP4K4ALOX15
SCHEMBL23300439 0.75 ADORA2A (0.43) CNR2KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL12508142 0.75 CNR2 (0.49) TSHRCNR2SMN1; SMN2
SCHEMBL3874091 0.75 TRPV1 (0.56) ADH5RXRARXRBMAP4K4TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9199965-B2 Benzoimidazole derivatives and pharmaceutical composition comprising the same DAEWOONG CO., LTD. (KR) 2015-12-01 US disclosed
EP-1861387-B1 BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF DAE WOONG PHARMA (KR) 2014-04-16 EP disclosed
CN-101128452-B Novel benzimidazole derivatives and pharmaceutical compositions containing the same DAE WOONG PHARMA 2012-11-21 CN disclosed
US-20090018124-A1 Novel Benzoimidazole Derivatives and Pharmaceutical Composition Comprising the Same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2009-01-15 US disclosed
CN-101128452-A Novel benzimidazole derivatives and pharmaceutical compositions containing the same DAE WOONG PHARMA (KR) 2008-02-20 CN disclosed
EP-1861387-A1 NOVEL BENZOIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2007-12-05 EP disclosed
WO-2006080821-A1 NOVEL BENZOIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2006-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018124-A1 Novel Benzoimidazole Derivatives and Pharmaceutical Composition Comprising the Same TRPV1, TRPA1, BDKRB2 ADH5 1486/4885MAP2K4 3482/4885RXRA 2920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.